NEVIRA nevirapine 200 mg tablets blister pack

Kraj: Australia

Język: angielski

Źródło: Department of Health (Therapeutic Goods Administration)

Składnik aktywny:

nevirapine, Quantity: 200 mg

Dostępny od:

Sun Pharma ANZ Pty Ltd

INN (International Nazwa):

Nevirapine

Forma farmaceutyczna:

Tablet, uncoated

Skład:

Excipient Ingredients: colloidal anhydrous silica; lactose monohydrate; microcrystalline cellulose; magnesium stearate; povidone; sodium starch glycollate type A

Droga podania:

Oral

Sztuk w opakowaniu:

14, 60, 100

Typ recepty:

(S4) Prescription Only Medicine

Wskazania:

Nevirapine in combination with antiretroviral agents is indicated for the treatment of HIV-1 infection in adults and adolescents over the age of 16 years.,Resistant virus emerges rapidly when Nevirapine is administered as monotherapy or in dual combination therapy with an antiretroviral agent. Therefore, nevirapine should always be administered in combination with at least two additional antiretroviral agents.

Podsumowanie produktu:

Visual Identification: White to off-white, oval-shaped, uncoated tablets with a break line on both sides and debossed with 'RX921' on one side.; Container Type: Blister Pack; Container Material: PVC/Al; Container Life Time: 36 Months; Container Temperature: Store below 25 degrees Celsius

Status autoryzacji:

Licence status A

Data autoryzacji:

2012-11-07